|
US to phase out OTC asthma inhalers citing environmental concerns
Pharmaceutical Business Review The United States Food and Drug Administration (FDA) announced that over-the-counter (OTC) asthma inhaler, Primatene Mist, containing chlorofluorocarbons (CFCs) will be taken off the US market from 31 December. The CFCs present in the product deplete … Teva Respiratory Provides Resources for Patients Impacted by PRIMATENE(R) MIST … |
View full post on asthma – Google News